Related references
Note: Only part of the references are listed.Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma
Ji Y. Park et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Clonal analysis revealed functional heterogeneity in cancer stem-like cell phenotypes in uterine endometrioid adenocarcinoma
Yuta Tabuchi et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
Vicky Makker et al.
LANCET ONCOLOGY (2019)
Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
Gaia Giannone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Superparamagnetic iron oxide nanoparticle-mediated expression of miR-326 inhibits human endometrial carcinoma stem cell growth
Yongtao Gao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1
Jing Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
Sarah J. Kitson et al.
CANCERS (2019)
Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications
Monica Marzagalli et al.
SEMINARS IN CANCER BIOLOGY (2019)
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Dong Yang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Endometrial Cancer Spheres Show Cancer Stem Cells Phenotype and Preference for Oxidative Metabolism
Maria Joao Carvalho et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma
Huan Lu et al.
EBIOMEDICINE (2019)
miR-27b-3p/MARCH7 regulates invasion and metastasis of endometrial cancer cells through Snail-mediated pathway
Ling Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2019)
Hormonal Regulation of Patient-Derived Endometrial Cancer Stem-like Cells Generated by Three-Dimensional Culture
Sachiko Shiba et al.
ENDOCRINOLOGY (2019)
Blocking NOTCH pathway can enhance the effect of EGFR inhibitor through targeting CD133+endometrial cancer cells
Chao Shang et al.
CANCER BIOLOGY & THERAPY (2018)
Cancer stem cells as targets for immunotherapy
Amy S. Codd et al.
IMMUNOLOGY (2018)
Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment
Yelei Guo et al.
PROTEIN & CELL (2018)
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer et al.
LANCET ONCOLOGY (2018)
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer
Megan Buechel et al.
MOLECULAR CANCER THERAPEUTICS (2018)
The Story of Imatinib in GIST - a Journey through the Development of a Targeted Therapy
Peter Reichardt
ONCOLOGY RESEARCH AND TREATMENT (2018)
Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells
Miseon Kim et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
71OPhase I extension study of ETC-159 an oral PORCN inhibitor administered with bone protective treatment, in patients with advanced solid tumours
D Tan et al.
ANNALS OF ONCOLOGY (2018)
Endometrial Stem Cell Markers: Current Concepts and Unresolved Questions
Nicola Tempest et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Estrogen induces cell proliferation by promoting ABCG2-mediated efflux in endometrial cancer cells
Takahiro Yaguchi et al.
BIOCHEMISTRY AND BIOPHYSICS REPORTS (2018)
Effects of metformin on endometrial cancer: Systematic review and meta-analysis
Cinthia G. Meireles et al.
GYNECOLOGIC ONCOLOGY (2017)
Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy
Ruediger Klapdor et al.
HUMAN GENE THERAPY (2017)
Autophagy plays an important role in sternness mediation and the novel dual function of EIG121 in both autophagy and sternness regulation of endometrial carcinoma JEC cells
Xiaomin Ran et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
Caner Saygin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
EMP2 is a novel therapeutic target for endometrial cancer stem cells
M. H. Kiyohara et al.
ONCOGENE (2017)
Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells
Baolan Gong et al.
TUMOR BIOLOGY (2017)
Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity
Gloria Mittica et al.
ONCOTARGET (2017)
MicroRNA-34a inhibits cells proliferation and invasion by downregulating Notch1 in endometrial cancer
Zhen Wang et al.
ONCOTARGET (2017)
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
Wei Xia Ang et al.
ONCOTARGET (2017)
5T4-specific chimeric antigen receptor modification promotes the immune efficacy of cytokine-induced killer cells against nasopharyngeal carcinoma stem cell-like cells
Xueyang Guo et al.
SCIENTIFIC REPORTS (2017)
Preliminary identification of endometrial cancer stem cells in vitro and in vivo
Fan-Fei Kong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
N. Colombo et al.
ANNALS OF ONCOLOGY (2016)
Wnt addiction of genetically defined cancers reversed by PORCN inhibition
B. Madan et al.
ONCOGENE (2016)
Endometrial cancer: Not your grandmother's cancer
Jessica N. McAlpine et al.
CANCER (2016)
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Piera Gargiulo et al.
CANCER TREATMENT REVIEWS (2016)
The Wnt signaling pathway in cancer
Yann Duchartre et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Progestin treatment decreases CD133+cancer stem cell populations in endometrial cancer
Michael S. Guy et al.
GYNECOLOGIC ONCOLOGY (2016)
Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer
Samah S. Elbasateeny et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Aldehyde dehydrogenase 1A1 in stem cells and cancer
Hiroyuki Tomita et al.
ONCOTARGET (2016)
Epigenetics in Cancer: A Hematological Perspective
Maximilian Stahl et al.
PLOS GENETICS (2016)
Phase II study of everolimus, letrozole, and metformin in women with advanced/recurrent endometrial cancer.
Pamela T. Soliman et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Zhenling Deng et al.
BMC IMMUNOLOGY (2015)
Clinical translation for endometrial cancer stem cells hypothesis
Maria Joao Carvalho et al.
CANCER AND METASTASIS REVIEWS (2015)
IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden
Marten van der Zee et al.
CANCER RESEARCH (2015)
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
Elena Gabriela Chiorean et al.
CLINICAL CANCER RESEARCH (2015)
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
Brian M. Slomovitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
A Big Bang model of human colorectal tumor growth
Andrea Sottoriva et al.
NATURE GENETICS (2015)
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Endometrial Cancer Stem Cell as a Potential Therapeutic Target
Satoru Kyo et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2015)
Cancer stem cell targeted therapy: progress amid controversies
Tao Wang et al.
ONCOTARGET (2015)
Molecular Pathways: Translational and Therapeutic Implications of the Notch Signaling Pathway in Cancer
Rebecca A. Previs et al.
CLINICAL CANCER RESEARCH (2015)
MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins
Yongtao Gao et al.
FEBS LETTERS (2015)
Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57
Xuekai Zhu et al.
ONCOTARGET (2015)
The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
Alessandro Allegra et al.
CANCER INVESTIGATION (2014)
Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells
Xiuzhi Zhang et al.
CANCER LETTERS (2014)
A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
Jordi Rodon et al.
CLINICAL CANCER RESEARCH (2014)
Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer
Daliah Tsoref et al.
GYNECOLOGIC ONCOLOGY (2014)
SPARC was overexpressed in human endometrial cancer stem-like cells and promoted migration activity
Nurismangul Yusuf et al.
GYNECOLOGIC ONCOLOGY (2014)
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study
Gini F. Fleming et al.
GYNECOLOGIC ONCOLOGY (2014)
Molecular characterization of CD133+ cancer stem-like cells in endometrial cancer
Mitsuhiro Nakamura et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
Peixin Dong et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Can we safely target the WNT pathway?
Michael Kahn
NATURE REVIEWS DRUG DISCOVERY (2014)
Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
N. Colombo et al.
BRITISH JOURNAL OF CANCER (2013)
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO
I. Ray-Coquard et al.
BRITISH JOURNAL OF CANCER (2013)
The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells
Soshi Kusunoki et al.
GYNECOLOGIC ONCOLOGY (2013)
Epithelial-to-mesenchytnal transition and stem cells in endometrial cancer
Cristina Mirantes et al.
HUMAN PATHOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
aSIRTing Control over Cancer Stem Cells
Takahiro Ito et al.
CANCER CELL (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Understanding cancer stem cell heterogeneity and plasticity
Dean G. Tang
CELL RESEARCH (2012)
microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer
Xiaoyan Qin et al.
ONCOLOGY LETTERS (2012)
Stem cells in endometrium and endometrial cancer: Accumulating evidence and unresolved questions
Satoru Kyo et al.
CANCER LETTERS (2011)
Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications
Nur Rahadiani et al.
CANCER SCIENCE (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1
Martin Goette et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Expression of the Stem Cell Marker, Nanog, in Human Endometrial Adenocarcinoma
Xi Zhou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2011)
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Sodium Butyrate Inhibits the Self-Renewal Capacity of Endometrial Tumor Side-Population Cells by Inducing a DNA Damage Response
Kiyoko Kato et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Endometrial Cancer Side-Population Cells Show Prominent Migration and Have a Potential to Differentiate into the Mesenchymal Cell Lineage
Kiyoko Kato et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Elimination of Human Lung Cancer Stem Cells through Targeting of the Stem Cell Factor-c-kit Autocrine Signaling Loop
Vera Levina et al.
CANCER RESEARCH (2010)
Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer
Mitsuhiro Nakamura et al.
HUMAN PATHOLOGY (2010)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
R. A. Nout et al.
LANCET (2010)
A cancer stem cell origin for human endometrial carcinoma?
Sonya A. Hubbard et al.
REPRODUCTION (2010)
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
Anne M. Friel et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2010)
Wnt signaling in stem and cancer stem cells
Peter Wend et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
The Value of Gynecologic Cancer Follow-Up Evidence-Based Ignorance?
Henrik Lajer et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Modified Radical Hysterectomy Versus Extrafascial Hysterectomy in the Treatment of Stage I Endometrial Cancer: Results From the ILIADE Randomized Study
Mauro Signorelli et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Differentiation therapy of leukemia: 3 decades of development
Daniel Nowak et al.
BLOOD (2009)
CD133 antigen expression in ovarian cancer
Gabriella Ferrandina et al.
BMC CANCER (2009)
Evidence for Cancer Stem Cells in Human Endometrial Carcinoma
Sonya A. Hubbard et al.
CANCER RESEARCH (2009)
Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors
Sergio Rutella et al.
CLINICAL CANCER RESEARCH (2009)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Expression of CD133-1 and CD133-2 in ovarian cancer
G. Ferrandina et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
BRCA1 regulates human mammary stem/progenitor cell fate
Suling Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer
Karen H. Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Overexpression of hedgehog signaling molecules and its involvement in the proliferation of endometrial carcinoma cells
Yu-Zhen Feng et al.
CLINICAL CANCER RESEARCH (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
c-Kit - A hematopoietic cell essential receptor tyrosine kinase
Charlotte E. Edling et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Follow-up after primary therapy for endometrial cancer: A systematic review
Michael Fung-Kee-Fung et al.
GYNECOLOGIC ONCOLOGY (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Stem cell origin of cancer and differentiation therapy
S Sell
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
LA Doyle et al.
ONCOGENE (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Hedgehog signaling in animal development: paradigms and principles
PW Ingham et al.
GENES & DEVELOPMENT (2001)
Share Paper
